Admit Therapeutics is developing a test that uses sequencing and a machine learning approach to measure methylation changes in mitochondrial DNA that can predict progression towards...
In the short term, the early detection test developed by ADmit Therapeutics will make it possible to optimize patient recruitment for clinical trials. People will be...